Protocols to recover negative-strand RNA viruses entirely from cDNA have be
en established in recent years, opening up this virus group to the detailed
analysis of molecular genetics and virus biology. The unique gene-expressi
on strategy of nonsegmented negative-strand RNA viruses, which involves rep
lication of ribonucleoprotein complexes and sequential synthesis of free mR
NAs, has also allowed the use of these viruses to express heterologous sequ
ences. There are advantages in terms of easy manipulation of constructs, hi
gh capacity for foreign sequences, genetically stable expression, and the p
ossibility of adjusting expression levels. Fascinating prospects for biomed
ical applications and transient gene therapy are offered by chimeric virus
vectors carrying novel envelope protein genes and targeted to defined host
cells.